Measuring the clinical response. What does it mean?THERASSE, P.European journal of cancer (1990). 2002, Vol 38, Num 14, pp 1817-1823, issn 0959-8049Article

Evaluation of response: new and standard criteriaTHERASSE, P.Annals of oncology. 2002, Vol 13, pp 127-129, issn 0923-7534, 3 p., SUP4Conference Paper

Nouvelles recommandations pour l'évaluation de la réponse tumorale dans les tumeurs solides = New guidelines to evaluate the response to treatment in solid tumorsDUFFAUD, F; THERASSE, P.Bulletin du cancer. 2000, Vol 87, Num 12, pp 881-886, issn 0007-4551Article

RECIST revisited : A review of validation studies on tumour assessmentTHERASSE, P; EISENHAUER, E. A; VERWEIJ, J et al.European journal of cancer (1990). 2006, Vol 42, Num 8, pp 1031-1039, issn 0959-8049, 9 p.Article

Clinical trials design and treatment tailoring : General principles applied to breast cancer researchTHERASSE, P; CARBONNELLE, S; BOGAERTS, J et al.Critical reviews in oncology/hematology. 2006, Vol 59, Num 2, pp 98-105, issn 1040-8428, 8 p.Article

Update in methodology and conduct of cancer clinical trialsTHERASSE, P; EISENHAUER, E. A; BUYSE, M et al.European journal of cancer (1990). 2006, Vol 42, Num 10, pp 1322-1330, issn 0959-8049, 9 p.Article

Addressing the challenge of intergroup studies in oncology: the EORTC experienceZURLO, A; THERASSE, P.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 4, pp S169-S172, issn 1359-6349Article

Response Assessment in Solid Tumours (RECIST): Version 1.1 and supporting papersEISENHAUER, E; VERWEIJ, J; THERASSE, P et al.European journal of cancer (1990). 2009, Vol 45, Num 2, issn 0959-8049, 88 p.Serial Issue

Quality assurance in medical oncology within the EORTCTHERASSE, P; DE MULDER, P. H. M.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 4, pp S152-S154, issn 1359-6349Article

Obstacles for independent transnational clinical trials in EuropeLACOMBE, D; THERASSE, P; MEUNIER, F et al.International journal of pharmaceutical medicine. 1998, Vol 12, Num 3, pp 133-136, issn 1364-9027Article

Medical fellowship programme within the Gynaecological Cancer Group of the European Organisation for Research and treatment of CancerWAGENAAR, H. C; TRIMBOS, J. B. M. Z; TEODOROVIC, I et al.Gynecologic and obstetric investigation. 2004, Vol 57, Num 2, pp 66-71, issn 0378-7346, 6 p.Article

Final results of a randomized phase III trial comparing cyclophosphamide, epirubicin, and fluorouracil with a dose-intensified epirubicin and cyclophosphamide + filgrastim as neoadjuvant treatment in locally advanced breast cancer: An EORTC-NCIC-SAKK Multicenter StudyTHERASSE, P; MAURIAC, L; WELNICKA-JASKIEWICZ, M et al.Journal of clinical oncology. 2003, Vol 21, Num 5, pp 843-850, issn 0732-183X, 8 p.Article

The challenges and achievements involved in implementing Quality of Life research in cancer clinical trialsBOTTOMLEY, A; VANVOORDEN, V; FLECHTNER, H et al.European journal of cancer (1990). 2003, Vol 39, Num 3, pp 275-285, issn 0959-8049, 11 p.Article

Statistical methodology of phase III cancer clinical trials: advances and future perspectivesSYLVESTER, R; VAN GLABBEKE, M; THERASSE, P et al.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 4, pp S162-S168, issn 1359-6349Article

The EORTC Breast Cancer Group: 40 years of research contributing to improve breast cancer managementTHERASSE, P; PICCART, M; VAN DE VELDE, C. J. H et al.European journal of cancer. Supplement (1990). 2002, Vol 38, Num 4, pp S39-S43, issn 1359-6349Article

Summary measures and statistics in the analysis of quality of life data : an example from an EORTC-NCIC-SAKK locally advanced breast cancer studyCURRAN, D; AARONSON, N; STANDAERT, B et al.European journal of cancer (1990). 2000, Vol 36, Num 7, pp 834-844, issn 0959-8049Article

TuBaFrost 3: Regulatory and ethical issues on the exchange of residual tissue for research across europeVAN VEEN, E.-B; RIEGMAN, P. H. J; VAN DAMME, B et al.European journal of cancer (1990). 2006, Vol 42, Num 17, pp 2914-2923, issn 0959-8049, 10 p.Article

Assessment of the value of confirming responses in clinical trials in oncology. CommentaryTHERASSE, P; EISENHAUER, E; GURPIDE, Alfonso et al.European journal of cancer (1990). 2005, Vol 41, Num 11, pp 1501-1502, issn 0959-8049, 7 p.Article

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10850 comparing modified radical mastectomy with tumorectomy plus tamoxifenFENTIMAN, I. S; VAN ZIJL, J; KARYDAS, I et al.European journal of cancer (1990). 2003, Vol 39, Num 3, pp 300-308, issn 0959-8049, 9 p.Article

The importance of quality assurance in surgical oncologyLANDHEER, M. L. E. A; THERASSE, P; VAN DE VELDE, C. J. H et al.European journal of surgical oncology. 2002, Vol 28, Num 6, pp 571-602, issn 0748-7983Article

Recommendations for the assessment of progression in randomised cancer treatment trialsDANCEY, J. E; DODD, L. E; FORD, R et al.European journal of cancer (1990). 2009, Vol 45, Num 2, pp 281-289, issn 0959-8049, 9 p.Article

Tubafrost 5 : Multifunctional central database application for a european tumor bankISABELLE, M; TEODOROUIC, I; OOMEN, M. H. A et al.European journal of cancer (1990). 2006, Vol 42, Num 18, pp 3103-3109, issn 0959-8049, 7 p.Article

Cancer Drug Development in Europe: A selection of new agents under Development at the European Drug Development networkLACOMBE, D; BUTLER-SMITH, A; THERASSE, P et al.Cancer investigation. 2003, Vol 21, Num 1, pp 137-147, issn 0735-7907, 11 p.Article

Locally advanced/inflammatory breast cancers treated with intensive epirubicin-based neoadjuvant chemotherapy: are there molecular markers in the primary tumour that predict for 5-year clinical outcome?BONNEFOI, H; DIEBOLD-BERGER, S; LARSIMONT, D et al.Annals of oncology. 2003, Vol 14, Num 3, pp 406-413, issn 0923-7534, 8 p.Article

Treatment of operable breast cancer in the elderly: a randomised clinical trial EORTC 10851 comparing tamoxifen alone with modified radical mastectomyFENTIMAN, I. S; CHRISTIAENS, M.-R; THERASSE, P et al.European journal of cancer (1990). 2003, Vol 39, Num 3, pp 309-316, issn 0959-8049, 8 p.Article